President & CEO — national & global medical device sales leader
Advancing New Technologies
Twenty-five-plus years of national and global medical device sales leadership, driving revenue growth, business transformation, and market expansion across spine, orthopedics, and neuromodulation — from U.S. territories to international markets. Nick partners with MedTech companies on commercial strategy, turnarounds, M&A integration, and global go-to-market execution.
Biocell Spine Consulting is led by Nick Ansari, a senior MedTech executive with more than 25 years of national and global medical device sales leadership — building and running commercial organizations across spine, orthopedics, and neuromodulation in both U.S. and international markets. He works directly with company leadership on the sales, marketing, and go-to-market decisions that determine whether a product or business actually grows.
That means designing the commercial strategy, building the sales and distributor structure to execute it, and staying close enough to the field — surgeons, reps, and channel partners — to know what's working and what needs to change. It's the same discipline he's applied running commercial operations for public and private MedTech companies, now brought directly to clients who need it.
Building the commercial strategy and sales structure that turns a product into consistent, forecastable revenue — across direct and distributor channels.
Integrated launch and market-expansion planning that gets new technologies in front of the right surgeons and accounts, faster — across national and international markets.
Diagnosing underperforming territories or business units and rebuilding them into top performers through structure, coaching, and disciplined execution.
Recruiting, training, and managing independent distributor networks to extend reach without sacrificing quality of execution.
Full P&L ownership of sales operations, forecasting, and reporting across national and global markets — the operating discipline that keeps growth plans honest.
Aligning sales organizations and go-to-market operations after an acquisition, and scaling commercial teams into new international markets.
Directs global commercial operations across U.S. and international markets, leading business transformation and turnaround initiatives with full P&L responsibility.
Led global sales strategy across direct and distributor channels, reversing a declining sales trend through structural and operational turnaround.
Head of Sales for Lanx, Inc., leading progressive P&L roles across U.S. and Eastern regional sales organizations. Grew company revenue from $40M to $100M in 18 months while scaling direct and independent distributor networks.
Turned an underperforming Mid-Atlantic territory into a top-performing region, delivering 122% of quota in consecutive years.
Built and ran a $13M independent distribution business, ranked in the top 10% of distributors nationally.
Drove adoption of spinal biologics across the Eastern U.S., converting over $20M in competitive business.